Dimensionality reduction of longitudinal 'omics data using modern tensor factorizations.

Journal: PLoS computational biology
Published Date:

Abstract

Longitudinal 'omics analytical methods are extensively used in the evolving field of precision medicine, by enabling 'big data' recording and high-resolution interpretation of complex datasets, driven by individual variations in response to perturbations such as disease pathogenesis, medical treatment or changes in lifestyle. However, inherent technical limitations in biomedical studies often result in the generation of feature-rich and sample-limited datasets. Analyzing such data using conventional modalities often proves to be challenging since the repeated, high-dimensional measurements overload the outlook with inconsequential variations that must be filtered from the data in order to find the true, biologically relevant signal. Tensor methods for the analysis and meaningful representation of multiway data may prove useful to the biological research community by their advertised ability to tackle this challenge. In this study, we present tcam-a new unsupervised tensor factorization method for the analysis of multiway data. Building on top of cutting-edge developments in the field of tensor-tensor algebra, we characterize the unique mathematical properties of our method, namely, 1) preservation of geometric and statistical traits of the data, which enable uncovering information beyond the inter-individual variation that often takes over the focus, especially in human studies. 2) Natural and straightforward out-of-sample extension, making tcam amenable for integration in machine learning workflows. A series of re-analyses of real-world, human experimental datasets showcase these theoretical properties, while providing empirical confirmation of tcam's utility in the analysis of longitudinal 'omics data.

Authors

  • Uria Mor
    Immunology Department, Weizmann Institute of Science, Rehovot 7610001, Israel.
  • Yotam Cohen
    Immunology Department, Weizmann Institute of Science, Rehovot 7610001, Israel.
  • Rafael Valdés-Mas
    Systems Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Denise Kviatcovsky
    Systems Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Eran Elinav
    Immunology Department, Weizmann Institute of Science, Rehovot 7610001, Israel; Cancer-Microbiome Division Deutsches Krebsforschungszentrum (DKFZ), Neuenheimer Feld 280, Heidelberg 69120, Germany. Electronic address: eran.elinav@weizmann.ac.il.
  • Haim Avron
    School of Mathematical Sciences, Tel Aviv University, Tel Aviv, Israel.